Abstract

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality

Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler

Issue: May/Jun 2020 - Volume 24, Number 3

Page(s): 194-197

Download in electronic PDF format for $75
  • Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Page 1
  • Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Page 2
  • Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Page 3
  • Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Page 4

Note: Electronic version includes supplemental material.

Abstract

Beta blockers (timolol 0.5% ophthalmic solution) delivered topically to the eyes or sublingually have recently been reported in case series and small placebo controlled studies to be effective in some cases of acute migraine. Rapid systemic absorption to achieve therapeutic levels of beta blockers is extremely important in the treatment of acute migraine. Nasal delivered beta blockers have been shown to be absorbed as fast as intravenous administration and seem ideal for acute migraine treatment. A nasal delivered beta-blocker spray has not been available. In 2019, O’Brien Pharmacy prepared a compounded timolol nasal spray that is now available to authorized prescribers. The theoretical basis for using nasal beta blocker spray is presented and research on fast-acting beta-blocker solutions for acute migraine is reviewed.

Related Keywords

  • acute migraine
  • beta-blockers
  • beta-adrenergic antagonists
  • timolol eye drops
  • nasal spray
  • intranasal administration
  • formulation
  • Mucolox gel
  • beta blockade contraindications

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Mar/Apr 2024
Pg. 129
Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine A New Therapeutic Modality
Author(s):
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Mar/Apr 2023
Pg. 153
Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal
Jul/Aug 2024
Pg. 286-290
Acute Migraine Treatment with Timolol 0.5% Nasal Spray - Compounding Pharmacists Have an Important Role
Author(s): Hagan John C III, Kosa Steven C, Chamberlain Tyler
Jul/Aug 2025
Pg. 259-266
Compounding Pharmacists: Key Educators on Timolol Nasal Spray for Acute Migraine
Author(s): Hagan John C
Jul/Aug 2017
Pg. 282-289
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Author(s): Choo Winnie
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2007
Pg. 520-524
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2012
Pg. 270-274
A Concise Discussion of Headache Types, Part 3: Migraine
Author(s): Williams LaVonn A, Allen Loyd V Jr
Sep/Oct 2000
Pg. 342
Compounding with Beta-1, 3-D-Glucan
Author(s): Keller Ted
Mar/Apr 2016
Pg. 147
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 150
Prochlorperazine Edisylate 0.5% Nasal Spray
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 418-419
Ipratropium Bromide 0.05% Nasal Spray
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 57
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 229
Dexpanthenol 5% Nasal Spray
Author(s): Allen Loyd V Jr
Nov/Dec 2009
Pg. 506-515
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
May/Jun 2013
Pg. 233
Labetalol 50-mg Capsules
Author(s): Allen Loyd V Jr